Abhishek Jain, the Chief Financial Officer of $CDNA, sold 265 shares of the company on 04-07-2025 for an estimated $4,695. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.1% of their shares of this class of stock. Following this trade, they now own 337,418 shares of this class of $CDNA stock.
$CDNA Insider Trading Activity
$CDNA insiders have traded $CDNA stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $CDNA stock by insiders over the last 6 months:
- GEORGE BICKERSTAFF sold 20,000 shares for an estimated $367,102
- JEFFREY ADAM NOVACK (Secretary and General Counsel) has made 0 purchases and 8 sales selling 13,110 shares for an estimated $297,873.
- PETER MAAG sold 5,000 shares for an estimated $125,000
- ABHISHEK JAIN (Chief Financial Officer) sold 265 shares for an estimated $4,695
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CDNA Hedge Fund Activity
We have seen 117 institutional investors add shares of $CDNA stock to their portfolio, and 91 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BELLEVUE GROUP AG removed 1,771,044 shares (-56.3%) from their portfolio in Q4 2024, for an estimated $37,918,052
- DIVISADERO STREET CAPITAL MANAGEMENT, LP added 711,761 shares (+inf%) to their portfolio in Q4 2024, for an estimated $15,238,803
- STATE STREET CORP added 623,010 shares (+30.6%) to their portfolio in Q4 2024, for an estimated $13,338,644
- ARK INVESTMENT MANAGEMENT LLC removed 579,497 shares (-19.4%) from their portfolio in Q4 2024, for an estimated $12,407,030
- FMR LLC removed 543,696 shares (-86.9%) from their portfolio in Q4 2024, for an estimated $11,640,531
- MACQUARIE GROUP LTD added 441,207 shares (+inf%) to their portfolio in Q4 2024, for an estimated $9,446,241
- GOLDMAN SACHS GROUP INC added 434,740 shares (+86.1%) to their portfolio in Q4 2024, for an estimated $9,307,783
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CDNA Analyst Ratings
Wall Street analysts have issued reports on $CDNA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 11/05/2024
To track analyst ratings and price targets for $CDNA, check out Quiver Quantitative's $CDNA forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
